Leavell Investment Management Inc. cut its stake in shares of Teleflex Incorporated (NYSE:TFX) by 12.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,950 shares of the medical technology company’s stock after selling 550 shares during the period. Leavell Investment Management Inc.’s holdings in Teleflex were worth $983,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of TFX. Atlanta Capital Management Co. L L C increased its position in Teleflex by 2.6% during the 2nd quarter. Atlanta Capital Management Co. L L C now owns 2,519,464 shares of the medical technology company’s stock worth $523,444,000 after purchasing an additional 64,985 shares during the period. Janus Henderson Group PLC grew its holdings in shares of Teleflex by 50,429.2% in the 2nd quarter. Janus Henderson Group PLC now owns 1,816,020 shares of the medical technology company’s stock worth $377,296,000 after acquiring an additional 1,812,426 shares during the period. State Street Corp grew its holdings in shares of Teleflex by 1.8% in the 2nd quarter. State Street Corp now owns 1,399,922 shares of the medical technology company’s stock worth $290,853,000 after acquiring an additional 25,401 shares during the period. American Century Companies Inc. grew its holdings in shares of Teleflex by 41.6% in the 3rd quarter. American Century Companies Inc. now owns 1,187,909 shares of the medical technology company’s stock worth $287,438,000 after acquiring an additional 348,829 shares during the period. Finally, Koch Industries Inc. lifted its stake in Teleflex by 47,174.3% in the 2nd quarter. Koch Industries Inc. now owns 959,669 shares of the medical technology company’s stock valued at $955,000 after buying an additional 957,639 shares in the last quarter. 89.29% of the stock is owned by hedge funds and other institutional investors.

In related news, CEO Benson Smith sold 2,000 shares of the stock in a transaction on Monday, December 4th. The stock was sold at an average price of $258.10, for a total value of $516,200.00. Following the transaction, the chief executive officer now directly owns 76,634 shares of the company’s stock, valued at approximately $19,779,235.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Stephen K. M.D. Klasko sold 200 shares of the stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $237.18, for a total value of $47,436.00. Following the completion of the transaction, the director now directly owns 8,080 shares in the company, valued at $1,916,414.40. The disclosure for this sale can be found here. Insiders sold a total of 2,600 shares of company stock worth $666,492 over the last ninety days. Corporate insiders own 2.39% of the company’s stock.

A number of equities research analysts recently issued reports on TFX shares. Deutsche Bank lowered Teleflex from a “buy” rating to a “hold” rating and set a $251.00 target price on the stock. in a research note on Tuesday, November 14th. Zacks Investment Research lowered Teleflex from a “buy” rating to a “hold” rating in a research note on Wednesday, October 4th. Needham & Company LLC upped their target price on Teleflex from $237.00 to $285.00 and gave the company a “buy” rating in a research note on Friday, November 3rd. Jefferies Group upped their target price on Teleflex from $270.00 to $295.00 and gave the company a “buy” rating in a research note on Friday, November 3rd. Finally, ValuEngine lowered Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and six have assigned a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $274.44.

Teleflex Incorporated (NYSE TFX) opened at $260.66 on Friday. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.72 and a quick ratio of 3.70. The firm has a market capitalization of $11,620.00, a price-to-earnings ratio of 47.05, a P/E/G ratio of 1.90 and a beta of 1.09. Teleflex Incorporated has a 52-week low of $162.79 and a 52-week high of $271.23.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, November 2nd. The medical technology company reported $2.12 earnings per share for the quarter, topping the consensus estimate of $2.01 by $0.11. The business had revenue of $534.70 million for the quarter, compared to analyst estimates of $522.94 million. Teleflex had a return on equity of 16.27% and a net margin of 12.41%. The business’s quarterly revenue was up 17.3% on a year-over-year basis. During the same period last year, the company posted $1.80 EPS. analysts predict that Teleflex Incorporated will post 8.36 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Friday, December 15th. Investors of record on Wednesday, November 15th were given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.52%. The ex-dividend date of this dividend was Tuesday, November 14th. Teleflex’s dividend payout ratio (DPR) is currently 24.55%.

ILLEGAL ACTIVITY WARNING: “Leavell Investment Management Inc. Has $983,000 Holdings in Teleflex Incorporated (TFX)” was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another website, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this story can be viewed at https://www.thecerbatgem.com/2018/01/12/leavell-investment-management-inc-has-983000-holdings-in-teleflex-incorporated-tfx.html.

Teleflex Company Profile

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.